Study Suggests a Widely Used Blood Pressure Drug May Raise Bleeding Risk

New research suggests that a commonly prescribed blood pressure medicine, especially calcium-channel blockers, could be tied to a higher chance of serious bleeding and certain gastrointestinal problems. The findings have raised questions for the many patients who depend on these drugs to manage hypertension.

Main Points

• Calcium-channel blockers may be associated with a greater risk of diverticulosis, a bowel condition.
• People taking diltiazem, a widely used calcium-channel blocker, may face a higher risk of bleeding-related complications.
• The results point to the need for more research into how these drugs may work in the body and what they could mean for prescribing decisions.

What Blood Pressure Medicines Do

Hypertension affects about one in ten adults worldwide and significantly increases the risk of heart attacks and strokes. Treatment often includes lifestyle changes as well as medication, and calcium-channel blockers are among the main drug classes used.

These medicines help lower blood pressure by relaxing blood vessels. Even so, recent studies have pointed to possible side effects, including concerns about gut health and bleeding.

Possible Connection to Diverticulosis

Researchers from Imperial College London and Ludwig Maximilian University in Munich found that some calcium-channel blockers, particularly the non-dihydropyridine type, may be linked with diverticulosis. The condition causes small pouches to form in the intestinal lining, and it can lead to serious problems if those pouches become inflamed or infected.

• Diverticulosis symptoms:
  • Abdominal pain, especially on the lower left side
  • Nausea and vomiting
  • Fever and abdominal tenderness
  • Constipation

The researchers analyzed genetic data from roughly 750,000 people and found that variants tied to these medications were linked with a higher likelihood of diverticulosis. They are still examining what may explain the relationship, including whether the drugs affect intestinal muscle function.

Diltiazem and Bleeding Risk

In another study published in JAMA, scientists looked at diltiazem, a common calcium-channel blocker, in people with atrial fibrillation. They found that those taking diltiazem together with anticoagulants were 20% more likely to be hospitalized for bleeding or die from bleeding-related causes than patients using other heart-rate-lowering drugs such as metoprolol.

• Key findings:
  • Higher doses of diltiazem were linked to greater bleeding risk.
  • There was no meaningful difference in stroke or systemic embolism rates between the two groups.

What This Means for Patients and Clinicians

The studies highlight the need for continued research into the side effects of commonly used medicines. Although the findings are concerning, experts say patients should not stop taking their medication without speaking to a healthcare provider.

Dr. Dipender Gill, a co-author of the diverticulosis study, said the results should not lead to immediate changes in prescribing guidance, but they should encourage more investigation into the safety of these drugs.

Closing Thoughts

As hypertension becomes more common, understanding the possible risks of blood pressure medications remains important. Patients and healthcare professionals need to stay informed about new evidence so they can balance effective treatment with safety. More studies are still needed to clarify the mechanisms behind these risks and guide future care.

Sources

• Blood pressure drug linked with increased risk of bowel condition | Imperial News, Imperial College London.
• Common blood pressure drug may harm gut health, Medical News Today.
• Common Blood Pressure Drug May Increase Risk of Bleeding, Northwestern University.